THE TRANSFORMING RECEPTOR TYROSINE KINASE, AXL, IS POSTTRANSLATIONALLY REGULATED BY PROTEOLYTIC CLEAVAGE

被引:143
作者
OBRYAN, JP
FRIDELL, YW
KOSKI, R
VARNUM, B
LIU, ET
机构
[1] UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CURRICULUM GENET,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,DEPT MED,CHAPEL HILL,NC 27599
[3] AMGEN CORP,THOUSAND OAKS,CA 91320
关键词
D O I
10.1074/jbc.270.2.551
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several receptor tyrosine kinases generate soluble ligand binding domains either by differential splicing resulting in a truncated RNA transcript, or by proteolytic cleavage, Although the exact role in vivo of these soluble extracellular domains is unclear, proteolysis may function to down-regulate the receptor, and soluble extracellular domains (ECD) may compete with the intact receptor binding to ligand, Ax1 is a member of a new class of receptor tyrosine kinases characterized by an ECD resembling cell adhesion molecules and unique sequences in the kinase domain, In addition, Ax1 is transforming in both fibroblast and hematopoietic cells, and appears to be involved in mesenchymal development, We now find that Ax1 is post-translationally processed by cleavage in a 14 amino acid region immediately NH2-terminal to the transmembrane domain resulting in a soluble ECD and a membrane bound kinase domain, The sequence of this putative cleavage site shares no homology with recognition sites of known proteases, Characterization of this proteolytic processing shows that it does not require protein synthesis or transport but is augmented by phorbol ester treatment, Since the cleavage of Ax1 enhances turnover of the kinase on the cell surface, we suggest that proteolytic processing down-regulates Ax1 kinase activity.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 36 条
[1]   ONCOGENIC ACTIVATION OF THE NEU-ENCODED RECEPTOR PROTEIN BY POINT MUTATION AND DELETION [J].
BARGMANN, CI ;
WEINBERG, RA .
EMBO JOURNAL, 1988, 7 (07) :2043-2052
[2]   LIGAND-INDEPENDENT ACTIVATION OF THE SEVENLESS RECEPTOR TYROSINE KINASE CHANGES THE FATE OF CELLS IN THE DEVELOPING DROSOPHILA EYE [J].
BASLER, K ;
CHRISTEN, B ;
HAFEN, E .
CELL, 1991, 64 (06) :1069-1081
[3]   INHIBITION OF TYROSINE KINASE-ACTIVITY OF THE EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR BY A TRUNCATED RECEPTOR FORM THAT BINDS TO EGF - ROLE FOR INTERRECEPTOR INTERACTION IN KINASE REGULATION [J].
BASU, A ;
RAGHUNATH, M ;
BISHAYEE, S ;
DAS, M .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :671-677
[4]   DIRECT EXPRESSION OF BORDETELLA-PERTUSSIS TOXIN SUBUNITS TO HIGH-LEVELS IN ESCHERICHIA-COLI [J].
BURNETTE, WN ;
MAR, VL ;
CIEPLAK, W ;
MORRIS, CF ;
KALJOT, KT ;
MARCHITTO, KS ;
SACHDEV, RK ;
LOCHT, C ;
KEITH, JM .
BIO-TECHNOLOGY, 1988, 6 (06) :699-706
[5]  
DAI W, 1994, ONCOGENE, V9, P975
[6]   LIFR-BETA AND GP-130 AS HETERODIMERIZING SIGNAL TRANSDUCERS OF THE TRIPARTITE CNTF RECEPTOR [J].
DAVIS, S ;
ALDRICH, TH ;
STAHL, N ;
PAN, L ;
TAGA, T ;
KISHIMOTO, T ;
IP, NY ;
YANCOPOULOS, GD .
SCIENCE, 1993, 260 (5115) :1805-1808
[7]   LIGAND AND PROTEIN KINASE-C DOWNMODULATE THE COLONY-STIMULATING FACTOR-I RECEPTOR BY INDEPENDENT MECHANISMS [J].
DOWNING, JR ;
ROUSSEL, MF ;
SHERR, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (07) :2890-2896
[8]   CLOSE SIMILARITY OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND V-ERB-B ONCOGENE PROTEIN SEQUENCES [J].
DOWNWARD, J ;
YARDEN, Y ;
MAYES, E ;
SCRACE, G ;
TOTTY, N ;
STOCKWELL, P ;
ULLRICH, A ;
SCHLESSINGER, J ;
WATERFIELD, MD .
NATURE, 1984, 307 (5951) :521-527
[9]  
FAUST M, 1992, ONCOGENE, V7, P1287
[10]  
FLETCHER BS, 1991, J BIOL CHEM, V266, P14511